Clinical Trial

Mitoxantrone Hydrochloride Liposome Combination Regimen in the Treatment of High-risk/Extramedullary Multiple Myeloma

Recruiting Phase 1/2
View on ClinicalTrials.gov →
Record status
This record was last updated February 7, 2024 (before its estimated November 30, 2025 completion). Its status may not reflect the trial's current state.
Summary
To evaluate the efficacy and safety of mitoxantrone Hydrochloride Hydrochloride Liposome combination regimen in the treatment of high-risk/extramedullary multiple myeloma
Trial Details
NCT Number NCT06246162
Lead Sponsor Affiliated Hospital of Nantong University
Conditions Multiple Myeloma
Enrollment 30 participants
Start Date 2023-11-13
Primary Completion 2025-11-30 (estimated)
Study Completion 2026-11-30 (estimated)
Updated on ClinicalTrials.gov 2024-02-07